Trending Reports

Quick Access to
Research Assistance

We can help you find what you need. Get in touch with us.

Get Alerts!

Receive e-mail alerts on latest market research

Asthma - Global Market Research

Asthma - Global Market Research

Refine Search
Show
per page

Global Asthma Market 2014-2018

About Asthma and its Categories Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the f....

Asthma | Sep 03rd, 2014 | by Technavio

Industry : Healthcare

Read more

$2,500

Spiriva (Asthma) - Forecast and Market Analysis to 2023

Spiriva (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Spiriva (Asthma) - Forecast and Market Analysis to 2023. The asthma market saw very slow growth over the past de....

Asthma | Aug 31st, 2014 | by GlobalData

Industry : Healthcare

Read more

$3,495

Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023

Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023. The asthma market saw very slow....

Asthma | Aug 31st, 2014 | by GlobalData

Industry : Healthcare

Read more

$3,495

Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023

Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023. The asthma market saw very sl....

Asthma | Aug 31st, 2014 | by GlobalData

Industry : Healthcare

Read more

$3,495

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023. The asthma market saw ver....

Asthma | Aug 31st, 2014 | by GlobalData

Industry : Healthcare

Read more

$3,495
Show
per page